GenSpera, Inc.

Developing Trailblazing Therapeutics

GenSpera's cutting-edge therapeutics tackle challenging areas in oncology

View Product Pipeline

About

About

GenSpera is a leader in developing prodrug therapeutics for some of the most challenging diseases in oncology, harnessing a cutting-edge platform technology to deliver a powerful plant-derived cytotoxin directly to tumors.

More About Genspera
Team

Team

GenSpera's team has deep experience in the pharmaceutical industry and drug discovery and development. Our scientific team includes leading researchers from around the globe.

View Leadership
Technology

Technology

Developed at Johns Hopkins University and the University of Copenhagen, GenSpera's patented technology platform that has the potential to work across a spectrum of drugs that precisely target different cancers.

Technology
Learn

Learn

Learn about GenSpera's development of mipsagargin.

View Video

Sign up for Email Alerts

Be the first to receive breaking news

Sign up Today